Verily’s ex-chief commercial officer sued the healthtech company for wrongful employment, citing HIPAA violations.
MM+M’s latest eBook explores how pharma brands can embrace AI to engage HCPs more effectively and become trusted partners by delivering relevant and meaningful content dynamically.
The U.S. will impose 100% tariffs on imported branded drugs from Oct. 1, 2025, exempting firms with U.S. projects. Pharma must localize, pursue deals, and manage unclear exemption rules.
A global pharma brand used Ostro Sites for HCPs to personalize oncology websites, boosting rep engagement, resource access, and HCP conversions.
The unified digital platform helps providers and patients access clear, compliant, and personalized pharmaceutical information with AI-powered tools.
Pharma is shifting from one-way email and SMS blasts to AI-driven, two-way, compliant conversations that deliver personalized, on-demand engagement for healthcare professionals.
The FDA has launched a two-pronged crackdown on drug ads, sending mass warnings to thousands of companies and secret cease-and-desist orders to 100 targeting specific promotions.
.svg)